Upregulation of soluble TNFR2 as treatment for Rheumatiod Arthritis
ERCOLE BIOTECH, INC. · Department of Health and Human Services
Phase II2008$1,345,970
DESCRIPTION (provided by applicant): The ultimate goal of this project, development of an anti-TNF-1 drug for rheumatoid arthritis and/or other TNF-1 induced inflammatory diseases, remains unchanged from the original ap…